TN2010000563A1 - Fgf 21 mutants and uses thereof - Google Patents
Fgf 21 mutants and uses thereofInfo
- Publication number
- TN2010000563A1 TN2010000563A1 TNP2010000563A TN2010000563A TN2010000563A1 TN 2010000563 A1 TN2010000563 A1 TN 2010000563A1 TN P2010000563 A TNP2010000563 A TN P2010000563A TN 2010000563 A TN2010000563 A TN 2010000563A TN 2010000563 A1 TN2010000563 A1 TN 2010000563A1
- Authority
- TN
- Tunisia
- Prior art keywords
- fgf21 mutant
- polypeptides
- fgf
- mutants
- mutant polypeptides
- Prior art date
Links
Abstract
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2009/046113 WO2009149171A2 (en) | 2008-06-04 | 2009-06-03 | Fgf21 mutants and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
TN2010000563A1 true TN2010000563A1 (en) | 2012-05-24 |
Family
ID=55024645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2010000563A TN2010000563A1 (en) | 2009-06-03 | 2010-12-03 | Fgf 21 mutants and uses thereof |
Country Status (1)
Country | Link |
---|---|
TN (1) | TN2010000563A1 (en) |
-
2010
- 2010-12-03 TN TNP2010000563A patent/TN2010000563A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502433A1 (en) | Fgf21 mutants and uses thereof | |
TN2011000161A1 (en) | Fgf21 mutants and uses thereof | |
MY152721A (en) | Fgf21 mutants and uses thereof | |
WO2010129600A3 (en) | Fgf21 mutants and uses thereof | |
MX2011013903A (en) | Chimeric fgf19 polypeptides and uses thereof. | |
MX2013005639A (en) | Methods of treating fgf21-associated disorders. | |
SG170086A1 (en) | Modified molecules which promote hematopoiesis | |
AP2011005814A0 (en) | Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases. | |
MX2012004548A (en) | Novel compositions for preventing and/or treating degenerative disorders of the central nervous system. | |
TN2010000563A1 (en) | Fgf 21 mutants and uses thereof | |
TN2011000553A1 (en) | Fgf21 mutants and uses thereof | |
UA102395C2 (en) | Fgf21 mutants and use thereof | |
WO2008033374A3 (en) | Ocl-2a3 compositions and uses thereof | |
TH158963A (en) | FGF21 Mutants and their use | |
TN2013000211A1 (en) | Methods of treating fgf 21- associated disorders |